Afya Limited - Class A Common Shares (AFYA)

Afya (NASDAQ:AFYA) outlined its strategy for expanding its healthcare education and digital-services ecosystem at its 2026 Afya Day, with executives emphasizing a proposed merger with Yduqs, planned synergy capture, shareholder returns and new growth avenues in medical education and physician-focuse

Medical education revenue grew 7% amid AI competition in clinical tools.

Afya (NASDAQ:AFYA) reported first-half 2026 revenue of BRL 1.985 billion, up 7% from a year earlier, while adjusted EBITDA rose 3% to BRL 918 million. Net income increased 7% to BRL 463 million, and basic earnings per share rose 9% to BRL 5.10. Chief Executive Officer Virgilio Gibbon said the compa

Afya Ltd. exemplifies quality investing with high ROIC, strong growth, and robust cash flow, making it a standout medical education stock in Brazil.

Afya (AFYA) Q3 2025 Earnings Call Transcript

Afya Ltd (AFYA) is a top Brazilian medical education stock. It shows strong profitability, high returns on capital, and solid growth, making it a standout quality investment.

AFYA Ltd. is a top Caviar Cruise screen pick, showcasing exceptional profitability with a 76.58% ROIC, strong earnings growth, and superior cash conversion in Brazil's medical education sector.

AFYA LTD (NASDAQ:AFYA) fits the Caviar Cruise stock screening strategy with strong ROIC, EBIT growth, debt management, and profit quality—ideal for long-term investors.